Edwards Lifesciences (EW) Short Interest Ratio & Short Volume → Did you make $29,000 two days with AI options trades? (From Prosper Trading Academy) (Ad) Free EW Stock Alerts $92.86 +0.55 (+0.60%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Edwards Lifesciences Short Interest DataCurrent Short Volume8,440,000 sharesPrevious Short Volume10,090,000 sharesChange Vs. Previous Month-16.35%Dollar Volume Sold Short$716.30 millionShort Interest Ratio / Days to Cover1.9Last Record DateFebruary 29, 2024Outstanding Shares601,300,000 sharesFloat Size591,880,000 sharesShort Percent of Float1.43%Today's Trading Volume2,899,680 sharesAverage Trading Volume4,195,340 sharesToday's Volume Vs. Average69% Short Selling Edwards Lifesciences ? Sign up to receive the latest short interest report for Edwards Lifesciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEW Short Interest Over TimeEW Days to Cover Over TimeEW Percentage of Float Shorted Over Time Ad Banyan Hill PublishingAI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit Edwards Lifesciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20248,440,000 shares $716.30 million -16.4%1.4%1.9 $84.87 2/15/202410,090,000 shares $868.35 million +1.3%1.7%2.3 $86.06 1/31/20249,960,000 shares $781.56 million -8.4%1.7%2.2 $78.47 1/15/202410,870,000 shares $804.71 million +2.0%1.8%2.4 $74.03 12/31/202310,660,000 shares $812.83 million -21.3%1.8%2.3 $76.25 12/15/202313,540,000 shares $1.04 billion +34.7%2.3%2.8 $76.90 Get the Latest News and Ratings for EW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edwards Lifesciences and its competitors with MarketBeat's FREE daily newsletter. 11/30/202310,050,000 shares $680.49 million -6.5%1.7%2.3 $67.71 11/15/202310,750,000 shares $720.36 million -6.3%1.8%2.6 $67.01 10/31/202311,470,000 shares $730.87 million -1.1%1.9%2.9 $63.72 10/15/202311,600,000 shares $821.05 million -13.4%1.9%3.1 $70.78 9/30/202313,400,000 shares $928.35 million +5.5%2.2%3.8 $69.28 9/15/202312,700,000 shares $929.64 million +18.1%2.1%4 $73.20 8/31/202310,750,000 shares $822.05 million +13.0%1.8%3.4 $76.47 8/15/20239,510,000 shares $759.47 million +0.4%1.6%3 $79.86 7/31/20239,470,000 shares $777.20 million -2.9%1.6%3.3 $82.07 7/15/20239,750,000 shares $910.46 million -0.9%1.6%3.7 $93.38 6/30/20239,840,000 shares $928.21 million -4.4%1.6%3.7 $94.33 6/15/202310,290,000 shares $939.37 million -7.4%1.7%3.8 $91.29 5/31/202311,110,000 shares $935.91 million +12.9%1.9%3.9 $84.24 5/15/20239,840,000 shares $874.97 million +7.2%1.6%3.2 $88.92 4/30/20239,180,000 shares $807.66 million -27.3%1.5%2.8 $87.98 4/15/202312,620,000 shares $1.06 billion -10.1%2.1%3.6 $84.36 3/31/202314,040,000 shares $1.16 billion -17.1%2.3%4.1 $82.73 3/15/202316,940,000 shares $1.35 billion +32.7%2.8%4.7 $79.48 2/28/202312,770,000 shares $1.03 billion +6.8%2.1%3.2 $80.44 2/15/202311,960,000 shares $931.92 million -12.4%2.0%3 $77.92 1/31/202313,650,000 shares $1.05 billion -2.0%2.2%3 $76.70 1/15/202313,930,000 shares $1.09 billion -9.2%2.3%2.7 $78.31 12/30/202215,340,000 shares $1.14 billion +9.9%2.5%3 $74.61 12/15/202213,960,000 shares $1.03 billion +27.0%2.3%2.8 $73.55 11/30/202210,990,000 shares $848.98 million +4.0%1.8%2.3 $77.25 11/15/202210,570,000 shares $802.90 million +30.3%1.7%2.5 $75.96 10/31/20228,110,000 shares $587.41 million +8.9%1.3%2.2 $72.43 10/15/20227,450,000 shares $614.03 million -1.7%1.2%2.7 $82.42 9/30/20227,580,000 shares $626.34 million +15.9%1.2%3 $82.63 9/15/20226,540,000 shares $620.52 million +77.7%1.1%2.5 $94.88 8/31/20223,680,000 shares $331.57 million -27.0%0.6%1.4 $90.10 8/15/20225,040,000 shares $527.89 million -9.0%0.8%2 $104.74 7/31/20225,540,000 shares $556.99 million -16.8%0.9%2.1 $100.54 7/15/20226,660,000 shares $662.20 million +7.3%1.1%2.4 $99.43Urgent new message from Porter Stansberry (Ad)I’ve been in the financial markets for close to three decades… Yet, I’ve never seen an opportunity that’s so urgent, so critical, and yet so overlooked than what is unfolding right now. You see, in one corner of the markets a financial anomaly has emerged that promises to be the single most important story of 2024.Click here now to get what could be the most urgent, and most lucrative research, my team has ever r EW Short Interest - Frequently Asked Questions What is Edwards Lifesciences' current short interest? Short interest is the volume of Edwards Lifesciences shares that have been sold short but have not yet been covered or closed out. As of February 29th, investors have sold 8,440,000 shares of EW short. 1.43% of Edwards Lifesciences' shares are currently sold short. Learn More on Edwards Lifesciences' current short interest. What is a good short interest ratio for Edwards Lifesciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EW shares currently have a short interest ratio of 2.0. Learn More on Edwards Lifesciences's short interest ratio. Which institutional investors are shorting Edwards Lifesciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Edwards Lifesciences: GTS Securities LLC, Wolverine Trading LLC, Paloma Partners Management Co, Caas Capital Management LP, Citadel Advisors LLC, Point72 Asset Management L.P., Cubist Systematic Strategies LLC, Capital Fund Management S.A., PEAK6 Investments LLC, Pura Vida Investments LLC, Capstone Investment Advisors LLC, Allianz Asset Management GmbH, IMC Chicago LLC, Concourse Financial Group Securities Inc., Genus Capital Management Inc., Simplex Trading LLC, and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Edwards Lifesciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.43% of Edwards Lifesciences' floating shares are currently sold short. Is Edwards Lifesciences' short interest increasing or decreasing? Edwards Lifesciences saw a drop in short interest during the month of February. As of February 29th, there was short interest totaling 8,440,000 shares, a drop of 16.4% from the previous total of 10,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edwards Lifesciences' float size? Edwards Lifesciences currently has issued a total of 601,300,000 shares. Some of Edwards Lifesciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edwards Lifesciences currently has a public float of 591,880,000 shares. How does Edwards Lifesciences' short interest compare to its competitors? 1.43% of Edwards Lifesciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Edwards Lifesciences: STERIS plc (2.50%), Intuitive Surgical, Inc. (0.93%), Zimmer Biomet Holdings, Inc. (2.39%), Align Technology, Inc. (2.35%), DexCom, Inc. (4.32%), Cencora, Inc. (4.86%), IQVIA Holdings Inc. (1.63%), Takeda Pharmaceutical Company Limited (0.20%), IDEXX Laboratories, Inc. (2.05%), Alcon Inc. (0.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Edwards Lifesciences stock? Short selling EW is an investing strategy that aims to generate trading profit from Edwards Lifesciences as its price is falling. EW shares are trading up $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edwards Lifesciences? A short squeeze for Edwards Lifesciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EW, which in turn drives the price of the stock up even further. How often is Edwards Lifesciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EW, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: STE Short Squeeze ISRG Short Squeeze ZBH Short Squeeze ALGN Short Squeeze DXCM Short Squeeze COR Short Squeeze IQV Short Squeeze TAK Short Squeeze IDXX Short Squeeze ALC Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:EW) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company